NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MyulA.00762.a: Short chain dehydrogenase

Target Characteristics

from organism: Mycobacterium ulcerans Agy99
most recent status: crystallized
center reference id: MyulA.00762.a
is community request: False
associated disease: Buruli, Bairnsdale ulcer
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MyulA.00762.a.A1.GE29734 Full length( MyulA.00762.a ) 1 262 GE29734
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

Proteins

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MyulA.00762.a.A1.PS00803 Full length( MyulA.00762.a ) 1 262

External Resources

Resource Reference ID
OrthoMCL: OG5_168406
PATRIC ID: fig|362242.7.peg.4795
RefSeq: YP_907636.1
UniProt: A0PUZ6

Enzyme & Pathway Information

Pathway Pathway ID EC Number
biotin biosynthesis I BIOTIN-BIOSYNTHESIS-PWY 1.1.1.100
(5Z)-dodecenoate biosynthesis I PWY0-862 1.1.1.100
superpathway of fatty acid biosynthesis I (E. coli) PWY0-881 1.1.1.100
arachidonate biosynthesis PWY-5353 1.1.1.100
petroselinate biosynthesis PWY-5367 1.1.1.100
cis-vaccenate biosynthesis PWY-5973 1.1.1.100
superpathway of mycolate biosynthesis PWY-6113 1.1.1.100
palmitoleate biosynthesis I (from (5Z)-dodec-5-enoate) PWY-6282 1.1.1.100
superpathway of unsaturated fatty acids biosynthesis (E. coli) PWY-6284 1.1.1.100
superpathway of fatty acids biosynthesis (E. coli) PWY-6285 1.1.1.100
8-amino-7-oxononanoate biosynthesis I PWY-6519 1.1.1.100
eicosapentaenoate biosynthesis from arachidonate PWY-6940 1.1.1.100
docosahexanoate biosynthesis II PWY-6951 1.1.1.100
docosahexanoate biosynthesis I PWY-7053 1.1.1.100
gondoate biosynthesis (anaerobic) PWY-7663 1.1.1.100
oleate biosynthesis IV (anaerobic) PWY-7664 1.1.1.100
(5Z)-dodecenoate biosynthesis II PWY-7858 1.1.1.100
mycolate biosynthesis PWYG-321 1.1.1.100

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MSLSEAPKEI AGHGLLADKV VVVTAAAGTG IGSATARRAL AEGADVVISD HHERRLGETA AELSALGLGR VESVLCDVSS TAQVDALIDS TTARMGRLDV LVNNAGLGGQ TPVADMIDDE WDRVLDVTLT SVFRATRAAL RYFREAPHGG VIVNNASVLG WRAQHSQSHY AAAKAGVMAL TRCSAIEAAE YGVRINAVSP SIARHKFLDK TTSAELLDRL SAGEAFGRAA EPWEVAATIA FLASEYSSYL TGEVISVSSQ HP

NT Sequence
ATGAGCTTGT CTGAAGCACC GAAAGAAATT GCCGGACATG GCCTTTTGGC TGACAAGGTC GTGGTGGTGA CCGCGGCGGC CGGCACCGGC ATCGGTTCGG CGACGGCGCG CCGTGCCCTG GCCGAAGGCG CCGACGTGGT GATTTCCGAC CACCACGAGC GACGGCTCGG CGAAACCGCC GCCGAACTGT CCGCGCTGGG ACTGGGCCGG GTCGAAAGCG TGCTGTGCGA CGTGAGTTCC ACCGCACAGG TCGACGCGCT GATCGACTCG ACCACCGCCC GCATGGGCCG CCTTGACGTG TTGGTCAACA ACGCCGGGTT GGGCGGGCAG ACCCCGGTGG CCGATATGAT CGACGACGAG TGGGATCGCG TCCTGGACGT GACGCTCACA TCGGTGTTCC GGGCCACTCG AGCCGCACTT CGCTACTTCC GTGAGGCGCC GCATGGTGGA GTGATCGTCA ACAATGCCAG CGTGTTGGGC TGGCGGGCAC AGCACTCGCA GTCGCACTAC GCCGCGGCCA AGGCCGGCGT CATGGCGTTA ACTCGCTGTA GCGCAATAGA AGCCGCGGAG TATGGGGTGC GGATCAATGC GGTGTCACCT AGCATCGCCC GGCACAAGTT CCTGGACAAG ACCACCTCTG CCGAGCTGCT CGACCGGCTG TCCGCCGGTG AGGCGTTCGG ACGCGCCGCC GAACCGTGGG AAGTGGCGGC CACCATCGCG TTTCTGGCCA GCGAGTACTC GAGCTATCTG ACCGGAGAGG TGATTTCGGT CTCCAGTCAG CACCCC

© 2021 Seattle Children's Research Institute. All rights reserved.